N@N

Larry Biegelsen Maintained (ABT) at Buy and Held Target at $155 on, Feb 22nd, 2022

Larry Biegelsen of Wells Fargo, Maintained "Abbott Laboratories" (ABT) at Buy and Held Target at $155 on, Feb 22nd, 2022.

Larry has made no other calls on ABT in the last 4 months.

There are 8 other peers that have a rating on ABT. Out of the 8 peers that are also analyzing ABT, 0 agree with Larry's Rating of Hold.

These are the ratings of the 8 analyists that currently disagree with Larry

---

• Cecilia Furlong of "Morgan Stanley" Maintained at Buy with Decreased Target to $151 on, Thursday, January 27th, 2022
• Jayson Bedford of "Raymond James" Maintained at Buy with Decreased Target to $143 on, Thursday, January 27th, 2022
• Matt Miksic of "Credit Suisse" Maintained at Buy with Increased Target to $139 on, Thursday, January 27th, 2022
• Matthew Taylor of "UBS" Maintained at Strong Buy with Increased Target to $142 on, Thursday, January 27th, 2022
• Robbie Marcus of "JP Morgan" Maintained at Buy and Held Target at $125 on, Saturday, January 22nd, 2022
• Joanna Wiensch of "Citigroup" Maintained at Strong Buy with Increased Target to $154 on, Wednesday, December 15th, 2021
• Shagun Singh of "RBC Capital" Initiated at Buy and Held Target at $146 on, Friday, December 10th, 2021
• James Mainwaring of "Atlantic Equities" Upgraded from Hold to Buy and Held Target at $144 on, Wednesday, October 27th, 2021

Contributing Sources

---